Literature DB >> 3882225

Monoclonal antibody-defined human pancreatic cancer-associated antigens.

W H Schmiegel, H Kalthoff, R Arndt, J Gieseking, H Greten, G Klöppel, C Kreiker, A Ladak, V Lampe, S Ulrich.   

Abstract

Three pancreatic cancer-associated antigens were characterized by use of monoclonal antibodies in immunobinding studies with various cellular and soluble target antigens, in immunoprecipitation, and in immunoperoxidase staining. C54-0 represents a tumor-associated Mr 122,000 antigen, which appears to be widely distributed on various epithelial tumors and to a lower extent on normal tissue. C1-N3 antigen exhibited a more restricted distribution, reacting with pancreatic and various gastrointestinal tract tumors as well as with chronically inflamed pancreatic tissue. The most specific antigen expression was observed for C1-P83 antigen, found on all exocrine tumors of the pancreas, but not on normal or chronically inflamed pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882225

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Human pancreatic adenocarcinoma-associated antigens defined by novel murine monoclonal antibodies Pak-1 and Pak-2.

Authors:  K Makisumi; K Takahashi; S Takako; S Sonoda
Journal:  Gastroenterol Jpn       Date:  1990-04

2.  Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.

Authors:  A Schott; I Vogel; U Krueger; H Kalthoff; H W Schreiber; W Schmiegel; D Henne-Bruns; B Kremer; H Juhl
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

3.  A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.

Authors:  K Bosslet; H F Kern; E J Kanzy; A Steinstraesser; A Schwarz; G Lüben; H U Schorlemmer; H H Sedlacek
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.

Authors:  W Schmiegel; C Roeder; J Schmielau; U Rodeck; H Kalthoff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

5.  CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.

Authors:  George A Abou-Rjaily; Sang Jun Lee; Denisa May; Qusai Y Al-Share; Anthony M Deangelis; Randall J Ruch; Michael Neumaier; Holger Kalthoff; Sue-Hwa Lin; Sonia M Najjar
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.

Authors:  M Dietel; H Arps; R Klapdor; S Müller-Hagen; M Sieck; L Hoffmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  [Immunohistochemistry in pancreatic cancer with new monoclonal antibodies].

Authors:  R Kübel; M Büchler; K Baczako; H G Beger
Journal:  Langenbecks Arch Chir       Date:  1987

8.  Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin.

Authors:  J Chin; R Zuna; F Miller
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

9.  The partial characterization and clinical evaluation of pancreas cancer-associated antigen from the ascites fluid of a patient with pancreatic cancer.

Authors:  M Saito; T Shimano; T Kobayashi; H Inaji; N Matsuura; S Masutani; T Mori
Journal:  Jpn J Surg       Date:  1991-07

10.  Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.

Authors:  G Moldenhauer; F Momburg; P Möller; R Schwartz; G J Hämmerling
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.